Published in Toxicol Pathol on January 16, 2002
Nonproliferative and proliferative lesions of the rat and mouse female reproductive system. J Toxicol Pathol (2014) 1.53
Granulosa cell tumor of the ovary and antecedent of adjuvant tamoxifen use for breast cancer. World J Surg Oncol (2010) 0.77
Raloxifene suppress proliferation-promoting function of estrogen in CaSKi cervical cells. Int J Clin Exp Med (2015) 0.75
Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence. Menopause (2015) 0.75
Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol (1968) 16.77
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (1988) 6.18
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol (1981) 3.96
Competition between, and effectiveness of, IgG and IgM antibodies in indirect fluorescent antibody and other tests. J Immunol (1967) 3.72
Natural and immune human antibodies reactive with antigens of virulent Neisseria gonorrhoeae: immunoglobulins G, M, And A. J Bacteriol (1967) 3.56
Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A (1985) 3.31
Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet (2001) 3.26
T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet (1986) 3.20
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science (1966) 3.00
Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science (1983) 2.96
Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest (1984) 2.66
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature (1981) 2.44
Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet (1988) 2.43
Peptide therapy for diabetes in NOD mice. Lancet (1994) 2.28
Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1990) 2.23
Serum antibody response in experimental human gonorrhoea. Immunoglobulins G, A, and M. Br J Vener Dis (1969) 2.17
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science (1988) 2.16
T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum (1985) 2.06
T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol (1983) 2.05
Antibiodies of the IgG, IgM, and IgA classes in newborn and adult sera reactive with gram-negative bacteria. J Clin Invest (1968) 1.98
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.97
The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J (1994) 1.87
Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol (1982) 1.84
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
Immune information, self-organization and meaning. Int Immunol (1998) 1.73
Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology (2012) 1.67
Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. J Am Acad Dermatol (1998) 1.64
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci (2000) 1.62
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum (1990) 1.60
Thymus-derived lymphocytes: humoral and cellular reactions distinguished by hydrocortisone. Science (1972) 1.58
T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol (1983) 1.58
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology (1990) 1.57
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science (1989) 1.56
Review of subchronic/chronic toxicity of antimony potassium tartrate. Regul Toxicol Pharmacol (1999) 1.51
Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med (1996) 1.47
Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene. Lab Invest (1997) 1.45
Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci (1999) 1.44
Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science (1982) 1.44
Effector T lymphocyte line cells migrate to the thymus and persist there. Nature (1982) 1.44
Transformation of thymocytes by thymus epithelium derived from AKR mice. Nature (1976) 1.43
Idiotypic immunization induces immunity to mutated p53 and tumor rejection. Nat Med (1998) 1.43
Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature (1984) 1.42
Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology (1996) 1.42
Regulation of autoimmune disease physiological and therapeutic. Immunol Rev (1986) 1.41
Low doses of low molecular weight heparin in vivo inhibits the elicitation of contact hypersensitivity. Acta Derm Venereol (1994) 1.39
Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction. J Exp Med (1970) 1.37
Autosensitization in vitro. J Exp Med (1971) 1.33
Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun (2000) 1.32
Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure. Proc Natl Acad Sci U S A (1987) 1.31
Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol (2000) 1.30
Ultrastructural and functional correlations of the parathyroid gland. Int Rev Exp Pathol (1974) 1.27
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
T lymphocyte lines induce autoimmune encephalomyelitis, delayed hypersensitivity and bystander encephalitis or arthritis. Eur J Immunol (1984) 1.25
Blood sulfonamide levels in feedlot cattle with respiratory disease. Mod Vet Pract (1973) 1.25
Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. J Immunol (1982) 1.24
Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes (1997) 1.24
Mechanisms of cancer-induced hypercalcemia. Lab Invest (1992) 1.23
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur J Immunol (1990) 1.22
Cell-free media of mixed lymphocyte cultures augmenting sensitization in vitro of mouse T lymphocytes against allogeneic fibroblasts. Eur J Immunol (1976) 1.22
Regulation of autosensitization. The immune activation and specific inhibition of self-recognizing thymus-derived lymphocytes. J Exp Med (1973) 1.20
A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci U S A (1996) 1.19
Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol (1987) 1.19
T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis. Transplant Rev (1972) 1.19
Induction of T-cells differentiation in vitro by thymus epithelial cells. Ann N Y Acad Sci (1975) 1.17
Structural and functional properties of adult rat heart myocytes lysed with digitonin. J Biol Chem (1985) 1.17
Thymus reticulum cell cultures confer T cell properties on spleen cells from thymus-deprived animals. Eur J Immunol (1973) 1.14
Rejection of tumor allografts by mouse spleen cells sensitized in vitro. J Exp Med (1971) 1.14
Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen. Nature (1977) 1.13
T lymphocytes with promiscuous cytotoxicity. Nature (1976) 1.13
Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol (1974) 1.13
Autosensitization of lymphocytes against thymus reticulum cells. Science (1972) 1.13
Specificity of T lymphocyte lines for peptides of myelin basic protein. J Immunol (1985) 1.13
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial. Diabetes Metab Res Rev (2007) 1.11
Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet (2000) 1.10
The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect. Cell Immunol (1970) 1.10
Fine structural and enzymatic evaluation of bone in thyroparathyroidectomized rats receiving various levels of vitamin D. Lab Invest (1973) 1.10
The ultrastructural effect of estrogens on bone cells in thyroparathyroidectomized rats. Am J Pathol (1977) 1.10
Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes (1994) 1.10
Vaccination against autoimmune encephalomyelitis (EAE): attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line. Eur J Immunol (1981) 1.09
Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab (1998) 1.09
Antigen-chip technology for accessing global information about the state of the body. Lupus (2006) 1.09
A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat-shock protein: adjuvant arthritis as a model for human rheumatoid arthritis. Curr Top Microbiol Immunol (1989) 1.09
Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J (1999) 1.08
Autoimmune encephalomyelitis: activation of thymus lymphocytes against syngeneic brain antigens in vitro. Science (1974) 1.08
Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic carcinoma. Patient with the syndrome of inappropriate secretion of antidiuretic hormone. J Clin Invest (1972) 1.07
NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun (1996) 1.07
Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin Exp Immunol (2008) 1.06
Cardiovascular procedures in patients with mental disorders. JAMA (2000) 1.06
Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. J Autoimmun (1999) 1.05
Histologic and ultrastructural evaluation of thyroid lesions associated with hypothyroidism in dogs. Vet Pathol (1981) 1.05
T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J Clin Invest (1992) 1.05
Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immunodominant epitope of basic protein. J Immunol (1986) 1.04
Lymphocyte receptors for autoantigens, autologous serum inhibits self-recognition. Nat New Biol (1973) 1.04
Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur J Immunol (2001) 1.04
Parathyroid hormone (PTH) secretion, PTH mRNA and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha on equine parathyroid cell function. J Mol Endocrinol (2003) 1.04
Autoimmunity can benefit self-maintenance. Immunol Today (2000) 1.04
Electron microscopic evaluation of bone cells in pigs with experimentally induced Bordetella rhinitis (turbinate osteoporosis). Am J Vet Res (1975) 1.04